Name: PDS Biotechnology Corporation (PDSB) Financial Statements
Creator: FinSpry

PDS Biotechnology Income Statement Analysis

Revenue, earnings, and profit margins in millions USD

Scale:

Scroll to see more

PDS Biotechnology Corporation income statement - Annual data in millions USD
Breakdown	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Dec 2024	Dec 2023	Dec 2022	Dec 2021	Dec 2020
Revenue & Gross Profit
Revenue	0.00	0.00	0.00	0.00	0.00
Cost of Revenue	0.06	0.00	0.00	0.00	0.00
Gross Profit	-0.06	0.00	0.00	0.00	0.00
Operating Expenses
Research & Development	22.57	27.76	29.43	11.25	7.92
Selling, General & Administrative	13.70	15.28	12.24	10.18	6.98
Operating Expenses	36.26	43.05	41.67	21.44	14.90
Operating Income	-36.32	-43.05	-41.67	-21.44	-14.90
Other Income/Expense
Interest Income	2.52	2.90	0.94	0.00	0.06
Interest Expense	4.67	-4.21	-1.32	0.00	0.00
Other Income/Expense	-2.16	0.00	0.00	0.00	0.00
Income
Income Before Tax	-38.48	-44.35	-42.05	-21.43	-14.85
Income Tax Expense	-0.87	-1.41	-1.20	-4.52	0.00
Net Income	-37.61	-42.94	-40.85	-16.92	-14.85
Net Income - Continuous Operations	-37.61	-42.94	-40.85	-16.92	0.00
Net Income - Discontinued Operations	0.00	0.00	0.00	0.00	0.00
EBITDA	-33.75	-42.99	-41.62	-21.43	-14.89
EBIT	-36.32	-43.05	-41.67	-21.43	-14.90
Depreciation & Amortization	0.06	0.06	0.05	0.01	0.02
Earnings Per Share
Basic EPS	-1.00	-1.00	-1.00	-1.00	-1.00
Diluted EPS	-1.00	-1.00	-1.00	-1.00	-1.00
Basic Shares Outstanding	36.45	30.95	28.60	25.60	16.75
Diluted Shares Outstanding	36.45	30.95	28.60	25.60	16.75